US Stocks

37 stocks covered, alphabetically. Each report shows quarterly and annual results, balance sheet, cash flow, guidance and events from the original filings, every figure with its source.

• 4D Molecular Therapeutics Inc. (FDMT)US35104E1001 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Strategic pivot, New market.
• Adtran Holdings (ADTN)US00486H1059 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Guidance cut, Guidance initiated.
• Alphabet Inc. (GOOGL)US02079K3059 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Net income doubled, Revenue accelerating, Margin expanding.
• Amplitude Inc. (AMPL)US03213A1043 · US · Nasdaq · Nasdaq CM · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin compressing, Revenue accelerating, Strategic pivot.
• Anika Therapeutics Inc. (ANIK)US0352551081 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-10Latest reading: Net income turned positive, Revenue accelerating, Guidance raised.
• ASP Isotopes Inc. (ASPI)US00218A1051 · US · Nasdaq · Nasdaq CM · Period 2026-Q2 · Updated 2026-10-09Latest reading: Revenue accelerating, Acquisition.
• AXT Inc. (AXTI)US00246W1036 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Operating income turned positive, Net income turned positive, Revenue accelerating.
• BioCryst Pharmaceuticals Inc. (BCRX)US09058V1035 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Operating income doubled, Net income doubled, Revenue accelerating, Cash flow inflection, Guidance raised, New market.
• Bloomin' Brands Inc. (BLMN)US0942351083 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin expanding, Guidance raised.
• Cerebras Systems Inc. (CBRS)US15675D1037 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Revenue decelerating, Net cash build, New market.
• Columbus McKinnon Corporation (CMCO)US1993331057 · US · Nasdaq · Nasdaq GS · Period 2027-Q1 · Updated 2026-10-09Latest reading: Revenue accelerating, Order intake, Margin compressing, Guidance raised.
• Conmed Corporation (CNMD)US2074101013 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Guidance confirmed.
• Dorman Products Inc. (DORM)US2582781009 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin expanding, Cash flow inflection, Guidance raised.
• Enovis Corporation (ENOV)US1940145022 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin expanding, Guidance confirmed.
• Five9, Inc. (FIVN)US3383071012 · US · Nasdaq · Nasdaq GM · Period 2026-Q2 · Updated 2026-10-10Latest reading: Net income doubled, Revenue accelerating, Margin compressing, Strategic pivot.
• FuelCell Energy, Inc. (FCEL)US35952H7008 · US · Nasdaq · Nasdaq GM · Period 2026-Q3 · Updated 2026-10-09Latest reading: Revenue decelerating, Net cash build, Guidance initiated, New market.
• Illumina Inc. (ILMN)US4523271090 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin compressing, Guidance raised.
• Integra LifeSciences Holdings Corporation (IART)US4579852082 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Net income turned positive, Cash flow inflection, Guidance cut, Strategic pivot.
• Intel Corporation (INTC)US4581401001 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Acquisition, Revenue accelerating, Margin expanding, Cash flow inflection.
• Ironwood Pharmaceuticals Inc. (IRWD)US46333X1081 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Net income doubled, Revenue decelerating, Guidance raised, Strategic pivot.
• Kaspi.kz JSC (KSPI)US48581R2058 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Revenue decelerating, Guidance confirmed, Acquisition.
• MaxLinear Inc. (MXL)US57776J1007 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Net income turned positive, EBITDA turned positive, Revenue accelerating, Margin expanding, Strategic pivot.
• Medifast Inc. (MED)US58470H1014 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Guidance initiated.
• Mesa Laboratories Inc. (MLAB)US59064R1095 · US · Nasdaq · Nasdaq GS · Period 2027-Q1 · Updated 2026-10-09Latest reading: Operating income doubled, Net income turned positive, Margin expanding, Strategic pivot.
• Microsoft Corporation (MSFT)US5949181045 · US · Nasdaq · Nasdaq GS · Period 2026-Q4 · Updated 2026-10-09Latest reading: New market.
• NCR Atleos Corporation (NATL)US63001N1063 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Margin expanding, Acquisition.
• Neogen Corporation (NEOG)US6404911066 · US · Nasdaq · Nasdaq GS · Period 2027-Q1 · Updated 2026-10-09Latest reading: Revenue accelerating, Margin expanding, Guidance raised, Divestiture.
• Nvidia (NVDA)US67066G1040 · US · Nasdaq · Nasdaq GS · Period 2027-Q2 · Updated 2026-10-09Latest reading: Operating income doubled, Net income doubled, Revenue accelerating, Net cash to net debt, Strategic pivot.
• Oracle Corporation (ORCL)US68389X1054 · US · NYSE · Period 2027-Q1 · Updated 2026-10-09Latest reading: Margin expanding, Revenue accelerating, Cash flow inflection, Strategic pivot.
• Pacira Biosciences Inc. (PCRX)US6951271005 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-10Latest reading: Divestiture, Cash flow inflection, New market.
• Pubmatic INC-CLASS A (PUBM)US74467Q1031 · US · Nasdaq · Nasdaq GM · Period 2026-Q2 · Updated 2026-10-10Latest reading: Revenue accelerating, Margin expanding, Strategic pivot.
• Remitly Global Inc. (RELY)US75960P1049 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-09Latest reading: Operating income doubled, Net income doubled, Cash flow inflection, Guidance raised.
• SolarEdge Technologies Inc. (SEDG)US83417M1045 · US · Nasdaq · Nasdaq GS · Period 2026-Q2 · Updated 2026-10-10Latest reading: Adjusted result turned positive, Revenue decelerating, Margin expanding, Strategic pivot.
• Spectrum Brands Holdings Inc. (SPB)US84790A1051 · US · NYSE · Period 2026-Q3 · Updated 2026-10-09Latest reading: Net income turned negative, Guidance raised.
• Super Micro Computer Inc. (SMCI)US86800U3023 · US · Nasdaq · Nasdaq GS · Period 2026-Q4 · Updated 2026-10-09Latest reading: Net debt to net cash, Operating income doubled, Net income doubled, Revenue decelerating, Margin expanding.
• The Cigna Group (CI)US1255231003 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Guidance raised, Strategic pivot.
• Xperi Inc. (XPER)US98423J1016 · US · NYSE · Period 2026-Q2 · Updated 2026-10-09Latest reading: Revenue accelerating, Margin expanding.